Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Prophase Labs ( (PRPH) ) is now available.
On January 22, 2026, ProPhase Labs, Inc. announced that its common stock had been approved for uplisting from the Pink Sheets to the OTCID Market. The move marks a significant step in enhancing the company’s trading venue, which may improve visibility and liquidity for its shares and is likely to be viewed as a positive development by existing and prospective shareholders.
The most recent analyst rating on (PRPH) stock is a Hold with a $0.13 price target. To see the full list of analyst forecasts on Prophase Labs stock, see the PRPH Stock Forecast page.
Spark’s Take on PRPH Stock
According to Spark, TipRanks’ AI Analyst, PRPH is a Neutral.
Overall score reflects weak financial performance (sharp revenue decline, negative margins, and negative cash flows) and strongly bearish technicals (well below moving averages with negative MACD). Offsetting factors are limited to mixed but potentially impactful earnings-call catalysts (collections and product partnering) and corporate actions that include both upside (strategic transaction potential) and significant risks (delisting/OTC and dilution-related volatility).
To see Spark’s full report on PRPH stock, click here.
More about Prophase Labs
Average Trading Volume: 1,169,804
Technical Sentiment Signal: Strong Sell
Current Market Cap: $879.2K
See more data about PRPH stock on TipRanks’ Stock Analysis page.